Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Linker for activation of T cells family member 2 (LAT2), also known as SLC7A8, LAB, NTAL, and other aliases, refers primarily to two distinct biological entities based on context: (1) an amino acid transporter protein of the solute carrier family 7 member 8 (SLC7A8), functioning as a heterodimer with 4F2hc (SLC3A2) and mediating the transport of neutral amino acids and thyroid hormones across cell membranes, and (2) a transmembrane adaptor protein (also called NTAL/LAB) involved in immune cell signaling, particularly within B cells, mast cells, and other hematopoietic lineages[1][3][5][7]. As a transporter, LAT2 is essential for nutrient exchange, homeostasis, and metabolic processes in multiple tissues, and dysfunction or altered expression has been linked to cancer metabolism and microvascular protection in diabetic retinopathy[2][3][4][6]. As an adaptor/scaffolding protein, LAT2 participates in the assembly of signal transduction complexes after receptor activation, modulating both adaptive and innate immune responses and tempering high-affinity IgE (FcεRI)-mediated reactions[5][7]. **Important note:** The term "LAT2" can refer to: - SLC7A8 (an amino acid transporter, also known as L-type amino acid transporter 2) - A transmembrane adaptor protein (NTAL/LAB, official gene symbol: LAT2) These are discrete, unrelated proteins with non-overlapping gene loci and distinct functions: the amino acid transporter is not related (structurally or genetically) to NTAL/LAB, despite the overlapping abbreviation[1][3][5][7].
Amino acid transport inhibition (e.g., LAT inhibitor reduces CD47 expression by inhibiting amino acid uptake); Indirect immune modulation (potential immunomodulation via amino acid availability/signaling complex assembly)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Linker for activation of T cells family member 2 (LAT2).